If Cardarine improves cholesterol, does that mean it is heart-safe?

No. Cardarine, or GW501516, is a PPAR-delta agonist rather than a SARM. A 12-week randomized trial in people with low HDL cholesterol found favorable changes in several lipid measures. That demonstrates an effect on measured biomarkers, not proof of fewer heart attacks, longer life, or safe bodybuilding use.[1]

WADA issued an unusual safety alert after serious toxicities were identified during preclinical development. Short human studies cannot rule out effects that require larger samples or longer exposure to detect. Conversely, animal findings do not supply a precise human risk percentage; the uncertainty is a reason for caution, not evidence that the concern can be ignored.[2]

A better lipid panel is only one part of evaluating a drug. Any claim that Cardarine “protects the heart” during steroid use would require evidence about the combination and clinically meaningful outcomes. Improvements in endurance or cholesterol do not demonstrate that another exposure’s risks have been canceled out.[1][2]